http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LV-10497-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a6959ba74d4d2939b3cd1b093af5ab0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-00 |
| filingDate | 1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e969a9eb53025931b75331223c051d46 |
| publicationDate | 1995-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | LV-10497-B |
| titleOfInvention | A method for obtaining a vaccine comprising polypeptides derived from the HIV-1 virus envelope gene |
| abstract | The AIDS vaccine containing HIV-I envelope protein is produced by cloning the HIV-I virus.nenveloping protein-encoding genes in baculovirus-insect cells in a vector system. Recombinant HIV-InProteins are purified, engineered, and adsorbed on aluminum phosphate adjuvant. These proteins are highly immunogenicnanimals. They cause the production of antibodies that bind to the HIV envelope and neutralize the in vitro activity of the virus.ntests |
| priorityDate | 1988-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.